Chronic cutaneous lupus erythematosus

Chronic cutaneous lupus erythematosus is the indication for 10 drugs in DrugBank. It is covered by 11 curated, structured indications.

Also known as: Discoid Lupus Erythematosus · Lupus Erythematosus, Discoid · Discoid Lupus Erythematosus (DLE) · Lupus Erythematosus, Chronic Cutaneous · discoid lupus erythematosis
Classified under: Immune System Diseases
Musculoskeletal and Connective Tissue Diseases
Indicated drugs: Betamethasone
Betamethasone phosphate
Bupivacaine
Chloroquine
Dexamethasone
Flumethasone
Methylprednisolone
Neomycin
Salicylic acid
Triamcinolone

Resolves to

Vocabularies

MeSHM0012756ICD-10L93SNOMED CT13902000MedDRA10013071UMLSC0024138

What you can answer from here — as of October 20, 2026

10Indicated drugsWith each drug's targets and mechanism

Listed above

11Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

40Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Chronic cutaneous lupus erythematosus share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.